The Use of Extracorporeal Membrane Oxygenation in Neonates With Congenital Renal Failure

Extracorporeal membrane oxygenation (ECMO) provides support for patients whose heart and lungs cannot oxygenate and circulate blood effectively. ECMO utilization in patients with congenital renal failure (CRF) is variable as are survival outcomes, ranging from 42 to 80 %. We aim to understand ECMO utilization and outcomes in patients with CRF at a free-standing, quaternary care children's hospital with a fetal care center.